SMO and neoplasm: This theory was supported by the in vivo treatment of MRT with a small-molecule inhibitor of Gli, which led to the decrease of Gli1 levels and inhibition of tumor growth, whereas Smo inhibitors had no effect (Jagani et al. 2010) (see Table 1).